Supernus hits Zydus with repeat suit over migraine drug

Supernus Pharmaceuticals has once again accused Indian generic drugmaker Zydus Cadila and its US unit of allegedly infringing 10 patents with its copycat of Trokendi XR (topiramate), a drug for migraines and seizures.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Fed Circuit opens door for additional pharma revenues in Supernus decision

24 January 2019 The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment owned by Supernus Pharmaceuticals.

Big Pharma

Zydus challenges ruling in Takeda antitrust dispute

16 June 2022 Zydus Pharmaceuticals has attempted to revive an antitrust lawsuit accusing Takeda Pharmaceuticals of attempting to delay generic competition and of abusing its dominant market position.

Big Pharma

Endo sues Indian drug maker over anti-smoking drug patent

10 August 2023 Patent-in-suit relates to a synthetic drug used to treat nicotine dependence | Development comes after USFood and Drug Administration sets new guidelines forcing the withdrawal of another big pharma firm’s rival drug.

More on this story

Americas

Fed Circuit opens door for additional pharma revenues in Supernus decision

24 January 2019 The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment owned by Supernus Pharmaceuticals.

Big Pharma

Zydus challenges ruling in Takeda antitrust dispute

16 June 2022 Zydus Pharmaceuticals has attempted to revive an antitrust lawsuit accusing Takeda Pharmaceuticals of attempting to delay generic competition and of abusing its dominant market position.

Big Pharma

Endo sues Indian drug maker over anti-smoking drug patent

More on this story

Americas

Fed Circuit opens door for additional pharma revenues in Supernus decision

24 January 2019 The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment owned by Supernus Pharmaceuticals.

Big Pharma

Zydus challenges ruling in Takeda antitrust dispute

16 June 2022 Zydus Pharmaceuticals has attempted to revive an antitrust lawsuit accusing Takeda Pharmaceuticals of attempting to delay generic competition and of abusing its dominant market position.

Big Pharma

Endo sues Indian drug maker over anti-smoking drug patent